News of Note—CDRH sent one warning letter to devicemakers this year

News of note

> In a sharp drop from the 18 warning letters it sent by July 2016, the FDA’s Center for Devices and Radiological Health issued a single warning letter this year—to St. Jude Medical about its implantable cardiac devices. Bloomberg story

> ExThera earned the FDA’s Expedited Access Pathway designation for its Seraph blood filter, a device designed to remove pathogens from whole blood. Release

> The FDA cleared Smiths Medical’s wireless, ambulatory infusion pump. Release


Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

Suggested Articles

Thermo Fisher Scientific has begun early talks to take over Dutch diagnostics maker Qiagen, according to reports.

Atomwise and Velocity Pharmaceutical Development co-founded a company to carry AI-derived drugs through preclinical testing and into takeout deals.

Sera Prognostics has raised $36 million in funding to help commercialize its blood test for assessing the risk of premature births.